Management of heart failure: Crossing boundary over to the surgical country

Surgical Clinics of North America

Volumn 84, Issue 1, 2004, Pages 1-25

  Dec, G William ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BOSENTAN; BUCINDOLOL; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR ANTAGONIST; EPLERENONE; HYDRALAZINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOSORBIDE DINITRATE; LISINOPRIL; LOSARTAN; METOPROLOL; RAMIPRIL; SPIRONOLACTONE; TEZOSENTAN; TRANDOLAPRIL; UNINDEXED DRUG; VALSARTAN; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ASSISTED CIRCULATION; CARDIOMYOPLASTY; CELL TRANSPLANTATION; CLINICAL FEATURE; CLINICAL TRIAL; DEFIBRILLATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DOSE RESPONSE; DRESSLER SYNDROME; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TARGETING; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE REVASCULARIZATION; HEART PACING; HEART TRANSPLANTATION; HEART VENTRICLE REMODELING; HOSPITALIZATION; HUMAN; ISCHEMIC HEART DISEASE; LIVER TOXICITY; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; MORBIDITY; MORTALITY; PHARMACOGENETICS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SUDDEN DEATH; SURGICAL TECHNIQUE; SURVIVAL; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 1242338888     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6109(03)00217-2     Document Type: Review

References (48)

1. Massie B.M., Shah N.B. Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. Am Heart J. 133:1997;703-712.
2. Lloyd-Jones D.M. The risk of congestive heart failure: sobering lessons from the Framingham Heart Study. Curr Cardiol Rep. 3:2001;184-190.
3. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult. Executive summary. Circulation. 104:2001;2996-3007.
4. Bax J.J., Poldermans D., Elhendy A., et al. Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. J Am Coll Cardiol. 34:1999;163-169.
5. Kim R.J., Wu E., Rafael A., et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 343:2000;1445-1453.
6. Middleborough L.L., Carson S., Tamariz M., et al. Results of revascularization in patients with severe left ventricular dysfunction. J Thorac Cardiovasc Surg. 119:2000;550-557.
7. Heart Failure Society of America. Guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction- pharmacological approaches. J Card Fail. 5:1999;357-382.
8. Packer M., Cohn J.N. Consensus recommendations for the management of chronic heart failure. Am J Cardiol. 1999;831A-838A.
9. McMurray J., Pfeffer M.A. New therapeutic options in congestive heart failure. Circulation. 105:2002;2099-2106.
10. Indications for ACE inhibitors in the early treatment of acute myocardial infarction. Systematic overview of individual data from 100,000 patients in randomized trials. Circulation. 97:1998;2202-2212.
11. Packer M., Poole-Wilson P.A., Armstrong P.W., et al. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. Circulation. 100:1999;2312-2317.
12. Burnier M. Angiotensin II type 1 receptor blockers. Circulation. 103:2001;904-912.
13. Pitt B., Poole-Wilson P.A., Segal R., et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomized trial-the Losartan Heart Failure Survival Study ELITE II. Lancent. 355:2000;1582-1587.
14. Cohn J.N., Tognoni G., for the Valsartan Heart Failure Trial Investigators. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med. 345:2001;1667-1675.
15. Jong P., Demers C., McKelvie R.S., et al. Angtiotensin receptor blockers in heart failure: meta-analysis of controlled trials. J Am Coll Cardiol. 39:2002;463-470.
16. Weber K.T. Aldosterone in congestive heart failure. N Engl J Med. 345:2001;1689-1697.
17. Pitt B., Zannad F., Remme W.J., et al. The effect of spironolactone on mortality and morbidity in patients with severe heart failure. N Engl J Med. 341:1999;709-717.
18. Bristow M.R. Beta-adrenergic receptor blockade in chronic heart failure. Circulation. 101:2000;558-569.
19. Packer M., Bristow M.R., Cohn J.N., et al., for the US Carvedilol Heart Failure Study Group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 334:1996;1340-1355.
20. McNamara D.M., Holubkov R., Janosko K., et al. Pharmacogenetic interactions between beta-blocker therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure. Circulation. 103:2001;1644-1648.
21. Krum H. New and emerging pharmacologic strategies in the management of chronic heart failure. Clin Cardiol. 23:2000;724-730.
22. Maisel A. B-type natriuretic peptide levels: a potential novel "white count" for congestive heart failure. J Card Fail. 7:2001;183-193.
23. Publication Committee for the VMAC Investigators. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive ehart failure. A controlled trial. JAMA. 287:2002;1531-1540.
24. Leclercq C., Kass D.A. Retiming the failing heart: principles and current clinical status of cardiac resynchronization. J Am Coll Cardiol. 39:2002;194-201.
25. Cazeau S., Lelercq C., Lavergne T., et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med. 2001;873-930.
26. Abraham W.T., Fisher W.G., Smith A.L., et al. Cardiac resynchronization in chronic heart failure. N Eng J Med. 346:2002;1845-1853.
27. Nelson G.S., Curry C.W., Wyman B.T., et al. Predictors of systolic augmentation form left ventricular preexcitation in patients with dilated cardiomyopathy and intraventricular conduction delay. Circulation. 101:2000;2703-2709.
28. Kass D.A. Surgical approaches to arresting or reversing chronic remodeling of the failing heart. J Card Fail. 4:1998;57-66.
29. Furnary A.P., Jessup F.M., Moreira L.P. Multicenter trial of dynamic cardiomyoplasty for chronic heart failure. Am J Cardiol. 28:1996;1175-1180.
30. Batista R.J., Verde J., Nery P., et al. Partial left ventriculectomy to treat end-stage heart disease. Ann Thorac Surg. 64:1997;634-638.
31. Schreuder J.J., Steendijk P., Van der Veen F.H., et al. Acute and short-term effects of partial ventriculectomy in dilated cardiomyopathy. Assessment by pressure-volume loops. J Am Coll Cardiol. 36:2000;2104-2114.
32. Starling R.C., McCarthy P.M., Buda T., et al. Results of partial left ventriculectomy for dilated cardiomyopathy. J Am Coll Cardiol. 36:2000;2098-2103.
33. Dor V., Sabatier M., DiDonato M., et al. Efficacy of endovascular patch plasty in large postinfarction akinetic scar and severe left ventricular dysfunction: comparison with a series of large dyskinetic scars. J Torac Cardiovasc Surg. 116:1998;50-59.
34. Athanasuleas C.L., Stanley A.W.H., Buckberg G.D., et al. Surgical anterior ventricular endocardial restoration (SAVER) in the dilated remodeled ventricle after anterior myocardial infarction. J Am Coll Cardiol. 37:2001;1199-1209.
35. Bolling S.F., Pagani F.D., Deeb G.M., et al. Intermediate-term outcome of mitral reconstruction in cardiomyopathy. J Thorac Cardiovasc Surg. 115:1998;381-388.
36. Konertz W.F., Kleber F.X., Dushe S., et al. Efficacy trends with the Acorn cardiac support device in patients with advanced heart failure. J Heart Fail. 7:2001;39.
37. Hosenpud J.D., Bennett L.E., Keck B.M., et al. The registry of the International Society for Heart and Lung Transplantation: eighteenth official report-2001. J Heart Lung Transplant. 20:2001;805-815.
38. Hunt S.A., Frazier O.H., Myers T.J. Mechanical circulatory support and cardiac transplantation. Circulation. 97:1998;2079-2090.
39. John R., Rajasinghe H.A., Itescu S., et al. Factors affecting long-term survival (>10 years) after cardiac transplantation in the cyclosporine era. J Am Coll Cardiol. 37:2001;189-194.
40. Taylor D.A., Atkins B.Z., Hungspreugs P., et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med. 4:1998;929-933.
41. Menasche P., Hagege A.A., Scorsin M., et al. Myoblast transplantation for heart failure. Lancet. 357:2001;279-280.
42. Goldstein D.J., Oz M.C., Rose E.A. Implantable left ventricular assist device. N Engl J Med. 339:1998;1522-1533.
43. Altemose G.T., Gritsus V., Jeevanandam V., et al. Altered myocardial phenotype after mechanical support in human beings with advanced cardiomyopathy. J Heart Lung Transplant. 16:1997;765-773.
44. Mann D.L., Taegtmeyer H. Dynamic regulation of the extracellular matrix after mechanical unloading of the failing human heart. Recovering the missing link in left ventricular remodeling. Circulation. 104:2001;1089-1091.
45. Dipla K., Mattiello J.A., Jeevanandam V., et al. Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure. Circulation. 97:1998;2316-2322.
46. Muller J., Wallukat G., Weng Y.-G., et al. Weaning from mechanical cardiac support in patients with idiopathic dialted cardiomyopathy. Circulation. 96:1997;542-549.
47. Morales D.L., Catanese K.A., Helman D.N., et al. Six year experience of caring for forty-four patients with a left ventricular assist device at home: Safe, economical, necessary. J Thorac Cardiovasc Surg. 119:2000;251-259.
48. Rose E.A., Gelijns A.C., Moskowitz A.J., et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 345:2001;1435-1443.